ATE72122T1 - Antivirale mischungen. - Google Patents

Antivirale mischungen.

Info

Publication number
ATE72122T1
ATE72122T1 AT88303651T AT88303651T ATE72122T1 AT E72122 T1 ATE72122 T1 AT E72122T1 AT 88303651 T AT88303651 T AT 88303651T AT 88303651 T AT88303651 T AT 88303651T AT E72122 T1 ATE72122 T1 AT E72122T1
Authority
AT
Austria
Prior art keywords
antiviral
blends
combinations
treatment
especially useful
Prior art date
Application number
AT88303651T
Other languages
English (en)
Inventor
Thomas Anthony Krenitsky
Thomas Paul Zimmerman
Phillip Allen Furman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE72122T1 publication Critical patent/ATE72122T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88303651T 1987-04-24 1988-04-22 Antivirale mischungen. ATE72122T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4215387A 1987-04-24 1987-04-24
EP88303651A EP0289229B1 (de) 1987-04-24 1988-04-22 Antivirale Mischungen

Publications (1)

Publication Number Publication Date
ATE72122T1 true ATE72122T1 (de) 1992-02-15

Family

ID=21920306

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88303651T ATE72122T1 (de) 1987-04-24 1988-04-22 Antivirale mischungen.

Country Status (4)

Country Link
EP (1) EP0289229B1 (de)
JP (1) JPS63280026A (de)
AT (1) ATE72122T1 (de)
DE (1) DE3868125D1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2831030B2 (ja) * 1989-05-12 1998-12-02 学校法人城西大学 ３’‐アジド‐３’デオキシチミジンを有効成分とする経皮投与製剤用組成物
EP0555302A1 (de) * 1990-10-30 1993-08-18 The Wellcome Foundation Limited Verfahren zur behandlung von dimyelinierenden krankheiten
GB9121815D0 (en) * 1991-10-15 1991-11-27 Delta Biotechnology Ltd Medicine
FR2746016B1 (fr) * 1996-03-15 1998-04-17 Combinaisons d'enzymes pour la destruction de cellules proliferatives
JP4110347B2 (ja) * 1999-11-05 2008-07-02 大鵬薬品工業株式会社 抗ｈｉｖ剤
WO2003025575A1 (en) * 2001-09-17 2003-03-27 Board Of Regents, The University Of Texas System Methods and compositions involving thymidine phosphorylase as a marker for hiv infection, aids progression, and drug resistance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178212A (en) * 1975-01-27 1979-12-11 Burroughs Wellcome Co. Stabilized thymidine phosphorylase formulation
GB1513461A (en) * 1975-01-27 1978-06-07 Wellcome Found Bacterial culture medium
EP0108285B1 (de) * 1982-10-14 1988-04-20 The Wellcome Foundation Limited Antivirale Purinderivate
ATE113603T1 (de) * 1985-03-16 1994-11-15 Wellcome Found Antivirale nukleoside.

Also Published As

Publication number Publication date
JPS63280026A (ja) 1988-11-17
EP0289229B1 (de) 1992-01-29
EP0289229A1 (de) 1988-11-02
DE3868125D1 (de) 1992-03-12

Similar Documents

Publication Publication Date Title
ATE185483T1 (de) Antivirale nucleosidkombination
TW366347B (en) Antiviral pharmaceutical compositions comprising 1,3-oxathiolane nucleoside analogues
IL101836A0 (en) Pharmaceutical compositions containing 1,3-oxathiolane nucleoside derivatives
CY1889A (en) Use of 3'-azido-3'-deoxythymidine in the treatment or prophylaxis of human retroviral infections
CA2005815A1 (en) Antiviral acyclic nucleoside derivatives
DK224286A (da) 2',3'-dideoxy-nucleosider
DE19575021I2 (de) Therapeutische Nucleoside
FI913236A0 (fi) 9-purinylfosfonsyraderivat.
CA2002648A1 (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
AP9300603A0 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
GR3000638T3 (en) Antiviral combination
IE882593L (en) Aristeromycin/adenosine derivatives
ATE72122T1 (de) Antivirale mischungen.
ATE71840T1 (de) Virushemmende nukleosidmischung.
IE893080L (en) Novel 2'-halomethylidene,2'-ethenylidene and¹2'-ethynyl adenosine derivatives
ATE147746T1 (de) Derivate von fluorphosphonat-nukleotiden
ATE186837T1 (de) Analoge des ajca-ribosids
FI895572A0 (fi) Antivirala foereningar.
IL85096A0 (en) Use of 3'-azido-3'-deoxythymidine in the treatment or prophylaxis of human retrovirus infection
MX9102245A (es) Combinaciones de compuestos vainilloides y compuestos antivirales de nucleosido para el tratamiento de infecciones de herpes

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties